Matthew Burns
-
I'm driven by the challenge of balancing compliance, commercial strategy, and operational efficiency, particularly in highly regulated environments. I take real satisfaction in solving complex problems, improving processes, and mentoring others. Whether it’s navigating a tricky supply chain issue or helping to build a robust quality system, I’m at my best when I’m bridging the gap between Quality and Operations to support safe, sustainable growth.
-
I’ve spent over a decade working across the pharmaceutical and medical device sectors, holding leadership roles in Quality, Operations and Supply Chain. I’ve acted as Responsible Person (RP) on multiple UK WDA(H) licences, and hold RPi and WQP credentials. My previous roles include Operations Manager and RP at multinational pharmaceutical manufacturer, Head of Operations at an innovative medical device developer, and most recently, Strategic Project and Planning Manager at a UK MAH and 3PL provider, where I also act as RP, and oversee key supply chain activities. My background gives me a unique, cross-functional perspective on regulatory compliance, commercial, logistics, and business transformation.
-
Actively supported batch releases as QP and also as RP in both the UK &EU for multiple clients in both clinical and commercial environments
Led over 150 audits across globe as an Independent Consultant
Developed seven new MIA/WDA licenses including transition of QMS from Clinical to Commercials
Four remediation projects in MHRA & USFDA environments
GMP design of IMP
Lead multiple GMP and QMS implementation projects
-
Regulatory leadership as RP, RPi, and WQP
Good Distribution Practice (GDP) and Quality Management Systems (QMS)
Root cause analysis and CAPA management
Technical and commercial project delivery
Operational planning and S&OP
Stakeholder and team engagement across QA, Commercial, and Supply Chain
Medical device knowledge (ISO 13485)
Controlled drugs management
-
Successfully hosting an MHRA GMDP inspections and leading CAPA development and execution
Played a key role in launching the UK’s first GSL Omeprazole 20mg product
Led the business integration of an £8M acquisition at Dexcel Pharma
Oversaw the migration of a GDP warehouse operation with minimal customer impact
Developed and validated automated testing systems for electrosurgical devices
Delivered engaging internal training on ICH Q9 and quality risk management